Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
NCT03831698
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Lynch Syndrome
Interventions
DRUG:
Omega-3 fatty acid ethyl esters (2 gram)
Sponsor
University of Kansas Medical Center